rs142704524
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_178452.6(DNAAF1):c.352+17G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0167 in 1,567,880 control chromosomes in the GnomAD database, including 280 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.014 ( 25 hom., cov: 33)
Exomes 𝑓: 0.017 ( 255 hom. )
Consequence
DNAAF1
NM_178452.6 intron
NM_178452.6 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.515
Publications
0 publications found
Genes affected
DNAAF1 (HGNC:30539): (dynein axonemal assembly factor 1) The protein encoded by this gene is cilium-specific and is required for the stability of the ciliary architecture. It is involved in the regulation of microtubule-based cilia and actin-based brush border microvilli. Mutations in this gene are associated with primary ciliary dyskinesia-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
DNAAF1 Gene-Disease associations (from GenCC):
- primary ciliary dyskinesia 13Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia
- primary ciliary dyskinesiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 16-84150359-G-C is Benign according to our data. Variant chr16-84150359-G-C is described in ClinVar as Benign. ClinVar VariationId is 262952.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0139 (2124/152326) while in subpopulation NFE AF = 0.0198 (1346/68040). AF 95% confidence interval is 0.0189. There are 25 homozygotes in GnomAd4. There are 1033 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR,AD gene
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DNAAF1 | NM_178452.6 | c.352+17G>C | intron_variant | Intron 3 of 11 | ENST00000378553.10 | NP_848547.4 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DNAAF1 | ENST00000378553.10 | c.352+17G>C | intron_variant | Intron 3 of 11 | 1 | NM_178452.6 | ENSP00000367815.5 | |||
| DNAAF1 | ENST00000567918.5 | n.352+17G>C | intron_variant | Intron 3 of 6 | 1 | ENSP00000455154.1 | ||||
| DNAAF1 | ENST00000563093.5 | n.352+17G>C | intron_variant | Intron 3 of 10 | 2 | ENSP00000457373.1 | ||||
| DNAAF1 | ENST00000570298.5 | n.506+17G>C | intron_variant | Intron 3 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0140 AC: 2125AN: 152208Hom.: 25 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
2125
AN:
152208
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0133 AC: 3339AN: 250818 AF XY: 0.0136 show subpopulations
GnomAD2 exomes
AF:
AC:
3339
AN:
250818
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0170 AC: 24097AN: 1415554Hom.: 255 Cov.: 25 AF XY: 0.0167 AC XY: 11817AN XY: 707422 show subpopulations
GnomAD4 exome
AF:
AC:
24097
AN:
1415554
Hom.:
Cov.:
25
AF XY:
AC XY:
11817
AN XY:
707422
show subpopulations
African (AFR)
AF:
AC:
111
AN:
32500
American (AMR)
AF:
AC:
449
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
AC:
302
AN:
25894
East Asian (EAS)
AF:
AC:
0
AN:
39440
South Asian (SAS)
AF:
AC:
355
AN:
85298
European-Finnish (FIN)
AF:
AC:
1287
AN:
53356
Middle Eastern (MID)
AF:
AC:
46
AN:
5692
European-Non Finnish (NFE)
AF:
AC:
20637
AN:
1069852
Other (OTH)
AF:
AC:
910
AN:
58848
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1105
2211
3316
4422
5527
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0139 AC: 2124AN: 152326Hom.: 25 Cov.: 33 AF XY: 0.0139 AC XY: 1033AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
2124
AN:
152326
Hom.:
Cov.:
33
AF XY:
AC XY:
1033
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
137
AN:
41564
American (AMR)
AF:
AC:
222
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
31
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
13
AN:
4834
European-Finnish (FIN)
AF:
AC:
239
AN:
10608
Middle Eastern (MID)
AF:
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
AC:
1346
AN:
68040
Other (OTH)
AF:
AC:
40
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
108
217
325
434
542
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
24
48
72
96
120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Primary ciliary dyskinesia 13 Benign:1
Oct 03, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.